{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:43:15Z","timestamp":1767339795961},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00103-020-03218-4","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T14:03:52Z","timestamp":1600178632000},"page":"1271-1286","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Schnelltestdiagnostik sexuell \u00fcbertragbarer Infektionen"],"prefix":"10.1007","volume":"63","author":[{"given":"Thomas","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Stefan","family":"Ro\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Sch\u00fcttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Buder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"M\u00fcnstermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Jochen","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Nick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Mau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"3218_CR1","unstructured":"WHO (2016) Global health sector strategy on sexually transmitted infections 2016\u20132021. Towards ending STIs. Report No.: WHO\/RHR\/16.09. Geneva: World Health Organization; 2016. https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/ghss-stis\/en\/. Zugegriffen: 14. Apr. 2020"},{"key":"3218_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley\u00a0J, Vander Hoorn\u00a0S, Korenromp\u00a0E et\u00a0al (2019) Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 97:548\u2013562P. https:\/\/doi.org\/10.2471\/BLT.18.228486","journal-title":"Bull World Health Organ"},{"key":"3218_CR3","doi-asserted-by":"publisher","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman\u00a0L, Rowley\u00a0J, Vander Hoorn\u00a0S et\u00a0al (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE 10:e143304. https:\/\/doi.org\/10.1371\/journal.pone.0143304","journal-title":"PLoS ONE"},{"key":"3218_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00105-016-3905-0","volume":"68","author":"P Nenoff","year":"2017","unstructured":"Nenoff\u00a0P, Manos\u00a0A, Ehrhard\u00a0I et al (2017) Non-viral sexually transmitted infections\u2014Epidemiology, clinical manifestations, diagnostics and therapy: Part\u00a01: Gonococci. Hautarzt 68:43\u201349. https:\/\/doi.org\/10.1007\/s00105-016-3905-0","journal-title":"Hautarzt"},{"key":"3218_CR5","unstructured":"BMG (2016) BIS 2030 \u2013 Strategie zur Eind\u00e4mmung von HIV, Hepatitis B und C und anderen sexuell \u00fcbertragbaren Infektionen. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Praevention\/Broschueren\/Strategie_BIS_2030_HIV_HEP_STI.pdf. Zugegriffen: 14. Apr. 2020"},{"key":"3218_CR6","unstructured":"Gesetz \u00fcber Medizinprodukte. http:\/\/www.gesetze-im-internet.de\/mpg\/index.html. Zugegriffen: 15. April 2020"},{"key":"3218_CR7","unstructured":"IVD-Verordnung 2017\/746: https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:32017R0746&from=DE. Zugegriffen: 15. April 2020"},{"key":"3218_CR8","unstructured":"Zentralstelle der L\u00e4nder f\u00fcr Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (2020) Benannte Stellen nach Verordnung (EU) 2017\/746 (IVDR). https:\/\/www.zlg.de\/medizinprodukte\/dokumente\/stellenlaboratorien\/benannte-stellen-eu-2017746-ivdr\/. Zugegriffen: 19. Juni 2020"},{"key":"3218_CR9","unstructured":"Nando (New Approach Notified and Designated Organisations) Information System Nando (new approach notified and designated organisations) information system. https:\/\/ec.europa.eu\/growth\/tools-databases\/nando\/index.cfm. Zugegriffen: 19. Juni 2020"},{"key":"3218_CR10","unstructured":"Zentralstelle der L\u00e4nder f\u00fcr Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (2020) Benannte Stellen nach Verordnung (EU) 2017\/745 (MDR). https:\/\/www.zlg.de\/medizinprodukte\/dokumente\/stellenlaboratorien\/benannte-stellen-eu-2017745-mdr\/. Zugegriffen: 19. Juni 2020"},{"key":"3218_CR11","unstructured":"Medizinprodukte-Anpassungsgesetz-EU \u2013 MPAnpG-EU https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Gesetze_und_Verordnungen\/GuV\/M\/MPAnpG-EU_RefE.pdf#page=1&zoom=auto,-82,496. Zugegriffen: 19. Juni 2020"},{"key":"3218_CR12","unstructured":"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329915\/WHO-CDS-HIV-19.30-eng.pdf?sequence=1&isAllowed=y. Zugegriffen: 19.\u00a0Juni 2020"},{"key":"3218_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00103-015-2174-x","volume":"58","author":"HF Rabenau","year":"2015","unstructured":"Rabenau\u00a0HF, Bannert\u00a0N, Berger\u00a0A et al (2015) Nachweis einer Infektion mit Humanem Immundefizienzvirus (HIV): Serologisches Screening mit nachfolgender Best\u00e4tigungsdiagnostik durch Antik\u00f6rper-basierte Testsysteme und\/oder durch HIV-Nukleins\u00e4ure-Nachweis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 58:877\u2013886. https:\/\/doi.org\/10.1007\/s00103-015-2174-x","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3218_CR14","unstructured":"Robert-Koch-Institut (RKI) (2019) HIV\/AIDS in Deutschland \u2013 Eckdaten der Sch\u00e4tzung. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/H\/HIVAIDS\/Eckdaten\/EckdatenDeutschland.pdf?__blob=publicationFile. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR15","first-page":"531","volume":"47","author":"Robert-Koch-Institut","year":"2017","unstructured":"Robert-Koch-Institut (RKI) (2017) Sch\u00e4tzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl der Menschen mit HIV in Deutschland. Epidemiol Bull 47:531\u2013545","journal-title":"Epidemiol Bull"},{"key":"3218_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00430-019-00655-0","volume":"209","author":"PR Wratil","year":"2020","unstructured":"Wratil\u00a0PR, Rabenau\u00a0HF, Eberle\u00a0J et al (2020) Comparative multi-assay evaluation of Determine\u2122 HIV-1\/2 Ag\/Ab Combo rapid diagnostic tests in acute and chronic HIV infection. Med Microbiol Immunol 209:139\u2013150. https:\/\/doi.org\/10.1007\/s00430-019-00655-0","journal-title":"Med Microbiol Immunol"},{"key":"3218_CR17","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1097\/QAD.0000000000001577","volume":"31","author":"D Donnell","year":"2017","unstructured":"Donnell\u00a0D, Ramos\u00a0E, Celum\u00a0C et al (2017) The effect of oral preexposure prophylaxis on the progression of HIV\u20111 seroconversion. AIDS 31:2007\u20132016. https:\/\/doi.org\/10.1097\/QAD.0000000000001577","journal-title":"AIDS"},{"key":"3218_CR18","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/infdis\/jiy120","volume":"217","author":"K Stefic","year":"2018","unstructured":"Stefic\u00a0K, Novelli\u00a0S, Mahjoub\u00a0N et\u00a0al (2018) Nonreactive human Immunodeficiency virus type 1 rapid tests after sustained viral suppression following antiretroviral therapy initiation during primary infection. J\u00a0Infect Dis 217:1793\u20131797. https:\/\/doi.org\/10.1093\/infdis\/jiy120","journal-title":"J Infect Dis"},{"key":"3218_CR19","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","volume":"19","author":"C Figueroa","year":"2015","unstructured":"Figueroa\u00a0C, Johnson\u00a0C, Verster\u00a0A, Baggaley\u00a0R (2015) Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav 19:1949\u20131965. https:\/\/doi.org\/10.1007\/s10461-015-1097-8","journal-title":"AIDS Behav"},{"key":"3218_CR20","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/S2352-3018(17)30023-1","volume":"4","author":"MS Jamil","year":"2017","unstructured":"Jamil\u00a0MS, Prestage\u00a0G, Fairley\u00a0CK et al (2017) Effect of availability of\u00a0HIV\u00a0self-testing\u00a0on\u00a0HIV\u00a0testing\u00a0frequency in gay and bisexual men at high risk of infection (FORTH): a\u00a0waiting-list randomised controlled trial. Lancet Hiv 4:e241\u2013e250. https:\/\/doi.org\/10.1016\/S2352-3018(17)30023-1","journal-title":"Lancet Hiv"},{"key":"3218_CR21","unstructured":"Paul-Ehrlich-Institut (2020) HIV-Selbsttests. https:\/\/www.pei.de\/DE\/newsroom\/hiv-selbsttests\/hiv-selbsttests-inhalt.html. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR22","doi-asserted-by":"publisher","first-page":"e00257","DOI":"10.1128\/JCM.00257-19","volume":"57","author":"K Steehler","year":"2019","unstructured":"Steehler\u00a0K, Siegler\u00a0AJ (2019) Bringing HIV self-testing to scale in the United States: a\u00a0review of challenges, potential solutions, and future opportunities. J\u00a0Clin Microbiol 57:e257. https:\/\/doi.org\/10.1128\/JCM.00257-19","journal-title":"J Clin Microbiol"},{"key":"3218_CR23","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2352-3018(18)30044-4","volume":"5","author":"C Figueroa","year":"2018","unstructured":"Figueroa\u00a0C, Johnson\u00a0C, Ford\u00a0N et al (2018) Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a\u00a0systematic review and meta-analysis. Lancet HIV 5:e277\u2013e290. https:\/\/doi.org\/10.1016\/S2352-3018(18)30044-4","journal-title":"Lancet HIV"},{"key":"3218_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/infdis\/jir789","volume":"205","author":"NE Rosenberg","year":"2012","unstructured":"Rosenberg\u00a0NE, Kamanga\u00a0G, Phiri\u00a0S et al (2012) Detection of acute HIV infection: a\u00a0field evaluation of the determine\u00ae HIV-1\/2 Ag\/Ab combo test. J\u00a0Infect Dis 205:528\u2013534. https:\/\/doi.org\/10.1093\/infdis\/jir789","journal-title":"J Infect Dis"},{"key":"3218_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcv.2017.06.006","volume":"94","author":"E Livant","year":"2017","unstructured":"Livant\u00a0E, Heaps\u00a0A, Kelly\u00a0C et\u00a0al (2017) The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J\u00a0Clin Virol 94:15\u201321. https:\/\/doi.org\/10.1016\/j.jcv.2017.06.006","journal-title":"J Clin Virol"},{"key":"3218_CR26","unstructured":"WHO (2019) hepatitis B fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR27","unstructured":"WHO (2016) Global health sector strategy on viral hepatitis 2016\u20132021. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf;jsessionid=1CA658EA0E48462FD08849988D926F91?sequence=1. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR28","unstructured":"WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC\u00a0BY-NC-SA\u00a03.0\u00a0IGO. http:\/\/www.who.int\/hepatitis\/publications\/guidelines-hepatitis-c-btesting\/en\/. Zugegriffen: 15. April 2020"},{"key":"3218_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00103-016-2496-3","volume":"60","author":"T Meyer","year":"2017","unstructured":"Meyer\u00a0T, Sch\u00fcttler\u00a0CG, Straube\u00a0E et al (2017) Schnelltest-Diagnostik sexuell \u00fcbertragbarer Infektionen in niedrigschwelligen Einrichtungen : Gemeinsame Stellungnahme des RKI, PEI und der DSTIG. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:245\u2013254. https:\/\/doi.org\/10.1007\/s00103-016-2496-3","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3218_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jcv.2017.11.005","volume":"98","author":"CC Chisenga","year":"2018","unstructured":"Chisenga\u00a0CC, Musukuma\u00a0K, Chilengi\u00a0R et al (2018) Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia. J\u00a0Clin Virol 98:5\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2017.11.005","journal-title":"J Clin Virol"},{"key":"3218_CR31","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1128\/JCM.02980-14","volume":"53","author":"HF Njai","year":"2015","unstructured":"Njai\u00a0HF, Shimakawa\u00a0Y, Sanneh\u00a0B et al (2015) Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. J\u00a0Clin Microbiol 53:1156\u20131163. https:\/\/doi.org\/10.1128\/JCM.02980-14","journal-title":"J Clin Microbiol"},{"key":"3218_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jviromet.2017.08.001","volume":"248","author":"JR Barbosa","year":"2017","unstructured":"Barbosa\u00a0JR, Colares\u00a0JKB, Flores\u00a0GL et\u00a0al (2017) Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients. J\u00a0Virol Methods 248:244\u2013249. https:\/\/doi.org\/10.1016\/j.jviromet.2017.08.001","journal-title":"J Virol Methods"},{"key":"3218_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/jclinpath-2018-205024","volume":"71","author":"JR Barbosa","year":"2018","unstructured":"Barbosa\u00a0JR, Cortes\u00a0VF, Portilho\u00a0MM et\u00a0al (2018) Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients. J\u00a0Clin Pathol 71:879\u2013884. https:\/\/doi.org\/10.1136\/jclinpath-2018-205024","journal-title":"J Clin Pathol"},{"key":"3218_CR34","doi-asserted-by":"publisher","first-page":"e22824","DOI":"10.1002\/jcla.22824","volume":"33","author":"JM Eko Mba","year":"2019","unstructured":"Eko Mba\u00a0JM, Bisseye\u00a0C, Mombo\u00a0LE et al (2019) Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon). J\u00a0Clin Lab Anal 33:e22824. https:\/\/doi.org\/10.1002\/jcla.22824","journal-title":"J Clin Lab Anal"},{"key":"3218_CR35","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12879-017-2772-3","volume":"17","author":"A Amini","year":"2017","unstructured":"Amini\u00a0A, Varsaneux\u00a0O, Kelly\u00a0H et al (2017) Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect Dis 17:698. https:\/\/doi.org\/10.1186\/s12879-017-2772-3","journal-title":"BMC Infect Dis"},{"key":"3218_CR36","unstructured":"WHO (2019) Performance evaluation acceptance criteria for HBsAg in vitro diagnostics in the context of WHO prequalification. https:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/hepb\/161125_who_performance_criteria_hbsag_ivd.pdf?ua=1.%20Accessed%2029%20January%202019;. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR37","unstructured":"Public reports of WHO prequalified IVDs for HBsAG https:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/pq-list\/hbsag\/public_report\/en\/. Zugegriffen: 15. April 2020"},{"key":"3218_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1423-0410.2009.01272.x","volume":"98","author":"H Scheiblauer","year":"2010","unstructured":"Scheiblauer\u00a0H, El-Nageh\u00a0M, Diaz\u00a0S et al (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a\u00a0geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98:403\u2013414. https:\/\/doi.org\/10.1111\/j.1423-0410.2009.01272.x","journal-title":"Vox Sang"},{"key":"3218_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3343\/alm.2018.38.6.578","volume":"38","author":"JH Ryu","year":"2018","unstructured":"Ryu\u00a0JH, Kwon\u00a0M, Moon\u00a0JD et\u00a0al (2018) Development of a\u00a0rapid automated fluorescent lateral flow immunoassay to detect hepatitis B surface antigen (HBsAg), antibody to HBsAg, and antibody to hepatitis C. Ann Lab Med 38:578\u2013584. https:\/\/doi.org\/10.3343\/alm.2018.38.6.578","journal-title":"Ann Lab Med"},{"key":"3218_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver (2018) EASL Recommendations on Treatment of Hepatitis C 2018. J\u00a0Hepatol 69:461\u2013511. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.026","journal-title":"J Hepatol"},{"key":"3218_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1365-2893.2001.00280.x","volume":"8","author":"C Colin","year":"2001","unstructured":"Colin\u00a0C, Lanoir\u00a0D, Touzet\u00a0S, Meyaud-Kraemer\u00a0L, Bailly\u00a0F, Trepo\u00a0C, HEPATITIS Group (2001) Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J\u00a0Viral Hepat 8:87\u201395. https:\/\/doi.org\/10.1046\/j.1365-2893.2001.00280.x","journal-title":"J Viral Hepat"},{"key":"3218_CR42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1128\/JCM.01640-09","volume":"48","author":"RS Ross","year":"2010","unstructured":"Ross\u00a0RS, Viazov\u00a0S, Salloum\u00a0S et\u00a0al (2010) Analytical performance characteristics and clinical utility of a\u00a0novel assay for total hepatitis C virus core antigen quantification. J\u00a0Clin Microbiol 48:1161\u20131168. https:\/\/doi.org\/10.1128\/JCM.01640-09","journal-title":"J Clin Microbiol"},{"key":"3218_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s1246-7820(01)00125-2","volume":"8","author":"MP Busch","year":"2001","unstructured":"Busch\u00a0MP (2001) Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 8:200\u2013206. https:\/\/doi.org\/10.1016\/s1246-7820(01)00125-2","journal-title":"Transfus Clin Biol"},{"key":"3218_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1055\/a-0599-1320","volume":"56","author":"C Sarrazin","year":"2018","unstructured":"Sarrazin\u00a0C, Zimmermann\u00a0T, Berg\u00a0T et al (2018) Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection\u2014AWMF-Register-No.: 021\/012. Z\u00a0Gastroenterol 56:756\u2013838. https:\/\/doi.org\/10.1055\/a-0599-1320","journal-title":"Z Gastroenterol"},{"issue":"Suppl 1","key":"3218_CR45","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1053\/jhep.2002.36815","volume":"36","author":"JM Pawlotsky","year":"2002","unstructured":"Pawlotsky\u00a0JM (2002) Use and interpretation of virological tests for hepatitis C. Hepatology 36(Suppl 1):S65\u2013S73. https:\/\/doi.org\/10.1053\/jhep.2002.36815","journal-title":"Hepatology"},{"key":"3218_CR46","first-page":"362","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC) (2013) Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 62:362\u2013365","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"3218_CR47","doi-asserted-by":"publisher","first-page":"e0121450","DOI":"10.1371\/journal.pone.0121450","volume":"10","author":"MS Khuroo","year":"2015","unstructured":"Khuroo\u00a0MS, Khuroo\u00a0NS, Khuroo\u00a0MS (2015) Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a\u00a0systematic review and meta-analysis. Plos One 10:e121450. https:\/\/doi.org\/10.1371\/journal.pone.0121450","journal-title":"Plos One"},{"issue":"2019","key":"3218_CR48","doi-asserted-by":"publisher","first-page":"e0210556","DOI":"10.1371\/journal.pone.0210556","volume":"14","author":"A Mane","year":"2019","unstructured":"Mane\u00a0A, Sacks\u00a0J, Sharma\u00a0S et al (2019) Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in India. Plos One 14(2019):e210556. https:\/\/doi.org\/10.1371\/journal.pone.0210556","journal-title":"Plos One"},{"key":"3218_CR49","doi-asserted-by":"publisher","first-page":"459.e1","DOI":"10.1016\/j.cmi.2016.01.009","volume":"22","author":"S Chevaliez","year":"2016","unstructured":"Chevaliez\u00a0S, Poiteau\u00a0L, Rosa\u00a0I et\u00a0al (2016) Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a\u00a0tool for improving access to care. Clin Microbiol Infect 22:459.e1\u2013459.e6. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.009","journal-title":"Clin Microbiol Infect"},{"key":"3218_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/tmi.12688","volume":"21","author":"CS Kosack","year":"2016","unstructured":"Kosack\u00a0CS, Nick\u00a0S (2016) Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings. Trop Med Int Health 21:603\u2013609. https:\/\/doi.org\/10.1111\/tmi.12688","journal-title":"Trop Med Int Health"},{"key":"3218_CR51","doi-asserted-by":"publisher","first-page":"ofv101","DOI":"10.1093\/ofid\/ofv101","volume":"2","author":"DG Fisher","year":"2015","unstructured":"Fisher\u00a0DG, Hess\u00a0KL, Erlyana\u00a0E, Reynolds\u00a0GL, Cummins\u00a0CA, Alonzo\u00a0TA (2015) Comparison of rapid point-of-care tests for detection of antibodies to hepatitis C virus. Open Forum Infect Dis 2:ofv101. https:\/\/doi.org\/10.1093\/ofid\/ofv101","journal-title":"Open Forum Infect Dis"},{"key":"3218_CR52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/JLP.JLP_172_19","volume":"11","author":"U Waheed","year":"2019","unstructured":"Waheed\u00a0U, Abdella\u00a0YE, Saba\u00a0NE et al (2019) Evaluation of screening effectiveness of hepatitis B surface antigen and anti-HCV rapid test kits in Pakistan. J\u00a0Lab Physicians 11:369\u2013372. https:\/\/doi.org\/10.4103\/JLP.JLP_172_19","journal-title":"J Lab Physicians"},{"key":"3218_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jviromet.2018.08.019","volume":"261","author":"L Poiteau","year":"2018","unstructured":"Poiteau\u00a0L, Soulier\u00a0A, Lemoine\u00a0M et\u00a0al (2018) Performance of a\u00a0new rapid diagnostic test for the detection of antibodies to hepatitis C virus. J\u00a0Virol Methods 261:153\u2013155. https:\/\/doi.org\/10.1016\/j.jviromet.2018.08.019","journal-title":"J Virol Methods"},{"key":"3218_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3892\/br.2017.959","volume":"7","author":"Y Waheed","year":"2017","unstructured":"Waheed\u00a0Y, Najmi\u00a0MH, Aziz\u00a0H, Waheed\u00a0H, Imran\u00a0M, Safi\u00a0SZ (2017) Prevalence of hepatitis C in people who inject drugs in the cities of Rawalpindi and Islamabad. Pak Biomed Rep 7:263\u2013266. https:\/\/doi.org\/10.3892\/br.2017.959","journal-title":"Pak Biomed Rep"},{"key":"3218_CR55","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/jmv.25405","volume":"91","author":"OJ Kweon","year":"2019","unstructured":"Kweon\u00a0OJ, Lim\u00a0YK, Kim\u00a0HR, Kim\u00a0TH, Lee\u00a0MK (2019) Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples. J\u00a0Med Virol 91:1056\u20131062. https:\/\/doi.org\/10.1002\/jmv.25405","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"3218_CR56","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12879-017-2773-2","volume":"17","author":"W Tang","year":"2017","unstructured":"Tang\u00a0W, Chen\u00a0W, Amini\u00a0A et al (2017) Diagnostic accuracy of tests to detect Hepatitis C antibody: a\u00a0meta-analysis and review of the literature. BMC Infect Dis 17(Suppl 1):695. https:\/\/doi.org\/10.1186\/s12879-017-2773-2","journal-title":"BMC Infect Dis"},{"key":"3218_CR57","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/infdis\/jir422","volume":"204","author":"BD Smith","year":"2011","unstructured":"Smith\u00a0BD, Drobeniuc\u00a0J, Jewett\u00a0A et\u00a0al (2011) Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J\u00a0Infect Dis 204:825\u2013831. https:\/\/doi.org\/10.1093\/infdis\/jir422","journal-title":"J Infect Dis"},{"key":"3218_CR58","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jcv.2012.07.016","volume":"55","author":"S Larrat","year":"2012","unstructured":"Larrat\u00a0S, Bourdon\u00a0C, Baccard\u00a0M et al (2012) Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture. J\u00a0Clin Virol 55:220\u2013225. https:\/\/doi.org\/10.1016\/j.jcv.2012.07.016","journal-title":"J Clin Virol"},{"key":"3218_CR59","volume-title":"Technical Specifications Series for submission to WHO Prequalification\u2014Diagnostic Assessment: Rapid diagnostic tests to detect hepatitis C antibody or antigen","author":"WHO","year":"2019","unstructured":"WHO (2019) Technical Specifications Series for submission to WHO Prequalification\u2014Diagnostic Assessment: Rapid diagnostic tests to detect hepatitis C antibody or antigen. World Health Organization, Geneva (Licence: CC BY-NC-SA 3.0 IGO. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/327936\/9789241516518-eng.pdf. Zugegriffen: 15. April 2020"},{"key":"3218_CR60","unstructured":"Public reports of WHO prequalified IVDs for HCV https:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/pq-list\/hcv\/public_report\/en\/. Zugegriffen: 15. April 2020"},{"key":"3218_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jcv.2018.02.016","volume":"102","author":"C Pallar\u00e9s","year":"2018","unstructured":"Pallar\u00e9s\u00a0C, Carvalho-Gomes \u00c2, Hontangas\u00a0V et al (2018) Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance. J\u00a0Clin Virol 102:77\u201383. https:\/\/doi.org\/10.1016\/j.jcv.2018.02.016","journal-title":"J Clin Virol"},{"key":"3218_CR62","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1128\/JCM.02460-16","volume":"55","author":"MP McHugh","year":"2017","unstructured":"McHugh\u00a0MP, Wu\u00a0AHB, Chevaliez\u00a0S, Pawlotsky\u00a0JM, Hallin\u00a0M, Templeton\u00a0KE (2017) Multicenter evaluation of the Cepheid Xpert hepatitis C virus viral load assay. J\u00a0Clin Microbiol 55:1550\u20131556. https:\/\/doi.org\/10.1128\/JCM.02460-16","journal-title":"J Clin Microbiol"},{"key":"3218_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcv.2017.01.006","volume":"88","author":"E Gupta","year":"2017","unstructured":"Gupta\u00a0E, Agarwala\u00a0P, Kumar\u00a0G, Maiwall\u00a0R, Sarin\u00a0SK (2017) Point-of-care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J\u00a0Clin Virol 88:46\u201351. https:\/\/doi.org\/10.1016\/j.jcv.2017.01.006","journal-title":"J Clin Virol"},{"key":"3218_CR64","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2468-1253(17)30075-4","volume":"2","author":"J Grebely","year":"2017","unstructured":"Grebely\u00a0J, Lamoury\u00a0FMJ, Hajarizadeh\u00a0B et al (2017) Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a\u00a0cohort study. Lancet Gastroenterol Hepatol 2:514\u2013520. https:\/\/doi.org\/10.1016\/S2468-1253(17)30075-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3218_CR65","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","volume":"217","author":"FMJ Lamoury","year":"2018","unstructured":"Lamoury\u00a0FMJ, Bajis\u00a0S, Hajarizadeh\u00a0B et al (2018) Evaluation of the Xpert HCV viral load finger-stick point-of-care assay. J\u00a0Infect Dis 217:1889\u20131896. https:\/\/doi.org\/10.1093\/infdis\/jiy114","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"3218_CR66","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12879-017-2770-5","volume":"17","author":"E Ivanova Reipold","year":"2017","unstructured":"Ivanova Reipold\u00a0E, Easterbrook\u00a0P, Trianni\u00a0A et\u00a0al (2017) Optimising diagnosis of viraemic hepatitis C infection: the development of a\u00a0target product profile. BMC Infect Dis 17(Suppl 1):707. https:\/\/doi.org\/10.1186\/s12879-017-2770-5","journal-title":"BMC Infect Dis"},{"key":"3218_CR67","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1136\/gutjnl-2018-316438","volume":"67","author":"M Lemoine","year":"2018","unstructured":"Lemoine\u00a0M, Tillmann\u00a0H (2018) What is required from HCV point-of care tests to reduce the burden of hepatitis C infection? \u2019Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 67:1916\u20131917. https:\/\/doi.org\/10.1136\/gutjnl-2018-316438","journal-title":"Gut"},{"key":"3218_CR68","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1136\/gutjnl-2017-315783","volume":"67","author":"A Llibre","year":"2018","unstructured":"Llibre\u00a0A, Shimakawa\u00a0Y, Mottez\u00a0E et al (2018) Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 67:2017\u20132024. https:\/\/doi.org\/10.1136\/gutjnl-2017-315783","journal-title":"Gut"},{"key":"3218_CR69","unstructured":"AWMF (2014) Diagnostik und Therapie der Syphilis. www.awmf.org\/uploads\/tx_szleitlinien\/059002l_S2k_Diagnostik_Therapie_Syphilis_2014_07.pdf. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR70","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1136\/sextrans-2016-053071","volume":"93","author":"I Toskin","year":"2017","unstructured":"Toskin\u00a0I, Murtagh\u00a0M, Peeling\u00a0RW, Blondeel\u00a0K, Cordero\u00a0J, Kiarie\u00a0J (2017) Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis. Sex Transm Infect 93:S69\u2013S80. https:\/\/doi.org\/10.1136\/sextrans-2016-053071","journal-title":"Sex Transm Infect"},{"key":"3218_CR71","unstructured":"Point-Of-Care Tests\u2014Target Product Profiles and Research Questions. https:\/\/www.who.int\/reproductivehealth\/POTC-TPPs-2016.pdf?ua=1. Zugegriffen: 15. April 2020"},{"key":"3218_CR72","doi-asserted-by":"publisher","first-page":"e54695","DOI":"10.1371\/journal.pone.0054695","volume":"8","author":"Y Jafari","year":"2013","unstructured":"Jafari\u00a0Y, Peeling\u00a0RW, Shivkumar\u00a0S et al (2013) Are Treponema pallidum specific rapid and point-ofcare tests for syphilis accurate enough for screening in resource limited settings? Evidence from a\u00a0meta-analysis. Plos One 8:e54695. https:\/\/doi.org\/10.1371\/journal.pone.0054695","journal-title":"Plos One"},{"key":"3218_CR73","unstructured":"Murtagh MM (2019) The point-of-care diagnostic landscape for sexually transmitted infections (STis). WHO 2019. https:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/Diagnostic-Landscape-for-STIs-2019.pdf. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR74","doi-asserted-by":"publisher","first-page":"e91504","DOI":"10.1371\/journal.pone.0091504","volume":"9","author":"LM Causer","year":"2014","unstructured":"Causer\u00a0LM, Kaldor\u00a0JM, Fairley\u00a0CK et al (2014) A laboratory-based evaluation of four rapid pointof-care tests for syphilis. Plos One 9:e91504. https:\/\/doi.org\/10.1371\/journal.pone.0091504","journal-title":"Plos One"},{"key":"3218_CR75","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/OLQ.0000000000000498","volume":"43","author":"E Nakku-Joloba","year":"2016","unstructured":"Nakku-Joloba\u00a0E, Kiragga\u00a0A, Mbazira\u00a0JK et al (2016) Clinical evaluation of 2\u00a0point-of-care lateral flow tests for the diagnosis of syphilis. Sex Transm Dis 43:623\u2013625. https:\/\/doi.org\/10.1097\/OLQ.0000000000000498","journal-title":"Sex Transm Dis"},{"key":"3218_CR76","doi-asserted-by":"publisher","first-page":"e00832","DOI":"10.1128\/JCM.00832-18","volume":"56","author":"LE Pereira","year":"2018","unstructured":"Pereira\u00a0LE, McCormick\u00a0J, Dorji\u00a0T et\u00a0al (2018) Laboratory evaluation of a\u00a0commercially available rapid syphilis test. J\u00a0Clin Microbiol 56:e832. https:\/\/doi.org\/10.1128\/JCM.00832-18","journal-title":"J Clin Microbiol"},{"key":"3218_CR77","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cid\/civ243","volume":"61","author":"LM Causer","year":"2015","unstructured":"Causer\u00a0LM, Kaldor\u00a0JM, Conway\u00a0DP et al (2015) An evaluation of a\u00a0novel dual treponemal\/nontreponemal point-of-care test for syphilis as a\u00a0tool to distinguish active from past treated infection. Clin Infect Dis 61:184\u2013191. https:\/\/doi.org\/10.1093\/cid\/civ243","journal-title":"Clin Infect Dis"},{"key":"3218_CR78","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1128\/JCM.02468-14","volume":"52","author":"RM Humphries","year":"2014","unstructured":"Humphries\u00a0RM, Woo\u00a0JS, Chung\u00a0JH, Sokovic\u00a0A, Bristow\u00a0CC, Klausner\u00a0JD (2014) Laboratory evaluation of three rapid diagnostic tests for dual detection of HIV and treponema pallidum antibodies. J\u00a0Clin Microbiol 52:4394\u20134397. https:\/\/doi.org\/10.1128\/JCM.02468-14","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"3218_CR79","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ijgo.2015.04.004","volume":"130","author":"YP Yin","year":"2015","unstructured":"Yin\u00a0YP, Ngige\u00a0E, Anyaike\u00a0C et\u00a0al (2015) Laboratory evaluation of three dual rapid diagnostic tests for HIV and syphilis in China and Nigeria. Int J Gynaecol Obstet 130(Suppl 1):S22\u2013S26. https:\/\/doi.org\/10.1016\/j.ijgo.2015.04.004","journal-title":"Int J Gynaecol Obstet"},{"key":"3218_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-0183567-x","volume":"19","author":"A Van den Heuvel","year":"2019","unstructured":"Van den Heuvel\u00a0A, Smet\u00a0H, Prat\u00a0I et\u00a0al (2019) Laboratory evaluation of four HIV\/syphilis rapid diagnostic tests. BMC Infect Dis 19:1. https:\/\/doi.org\/10.1186\/s12879-0183567-x","journal-title":"BMC Infect Dis"},{"key":"3218_CR81","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1128\/JCM.00637-16","volume":"54","author":"S Herbst de Cortina","year":"2016","unstructured":"Herbst de Cortina\u00a0S, Bristow\u00a0CC, Vargas\u00a0SK et al (2016) Laboratory evaluation of a\u00a0point-of-care downward-flow assay for simultaneous detection of antibodies to treponema pallidum and human Immunodeficiency virus. J\u00a0Clin Microbiol 54:1922\u20131924. https:\/\/doi.org\/10.1128\/JCM.00637-16","journal-title":"J Clin Microbiol"},{"issue":"S4","key":"3218_CR82","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1136\/sextrans-2016-053069","volume":"93","author":"HD Gliddon","year":"2017","unstructured":"Gliddon\u00a0HD, Peeling\u00a0RW, Kamb\u00a0ML, Toskin\u00a0I, Wi\u00a0TE, Taylor\u00a0MM (2017) A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect 93(S4):S3\u2013S15. https:\/\/doi.org\/10.1136\/sextrans-2016-053069","journal-title":"Sex Transm Infect"},{"issue":"S4","key":"3218_CR83","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1136\/sextrans-2016-053067","volume":"93","author":"H Kelly","year":"2017","unstructured":"Kelly\u00a0H, Coltart\u00a0CEM, Pant Pai\u00a0N et al (2017) Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Infect 93(S4):S22\u2013S30. https:\/\/doi.org\/10.1136\/sextrans-2016-053067","journal-title":"Sex Transm Infect"},{"key":"3218_CR84","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1136\/sextrans-2017-053192","volume":"93","author":"RJ Guy","year":"2017","unstructured":"Guy\u00a0RJ, Causer\u00a0LM, Klausner\u00a0JD et al (2017) Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections. Sex Transm Infect 93:S16\u2013S21. https:\/\/doi.org\/10.1136\/sextrans-2017-053192","journal-title":"Sex Transm Infect"},{"key":"3218_CR85","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1128\/JCM.03603-14","volume":"53","author":"NS Abbai","year":"2015","unstructured":"Abbai\u00a0NS, Moodley\u00a0P, Reddy\u00a0T et al (2015) Clinical evaluation of the onestep gonorrhea rapicard Instatest for detection of\u00a0Neisseria\u00a0gonorrhoeae in symptomatic patients from KwaZulu-natal, south africa. J\u00a0Clin Microbiol 53:1348\u20131350. https:\/\/doi.org\/10.1128\/JCM.03603-14","journal-title":"J Clin Microbiol"},{"key":"3218_CR86","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3343\/alm.2015.35.1.50","volume":"35","author":"JY Ham","year":"2015","unstructured":"Ham\u00a0JY, Jung\u00a0J, Hwang\u00a0BG et al (2015) Highly sensitive and novel point-of-care system, aQcare Chlamydia TRF kit for detecting Chlamydia trachomatis by using europium (Eu) (III) chelated nanoparticles. Ann Lab Med 35:50\u201356. https:\/\/doi.org\/10.3343\/alm.2015.35.1.50","journal-title":"Ann Lab Med"},{"key":"3218_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ab.2012.06.005","volume":"428","author":"E Juntunen","year":"2012","unstructured":"Juntunen\u00a0E, Myyryl\u00e4inen\u00a0T, Salminen\u00a0T, Soukka\u00a0T, Pettersson\u00a0K (2012) Performance of fluorescent europium (III) nanoparticles and colloidal gold reporters in lateral flow bioaffinity assay. Anal Biochem 428:31\u201338. https:\/\/doi.org\/10.1016\/j.ab.2012.06.005","journal-title":"Anal Biochem"},{"key":"3218_CR88","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s10156-004-0322-6","volume":"10","author":"K Suzuki","year":"2004","unstructured":"Suzuki\u00a0K, Matsumoto\u00a0T, Murakami\u00a0H et\u00a0al (2004) Evaluation of a\u00a0rapid antigen detection test for Neisseria gonorrhoeae in urine sediment for diagnosis of gonococcal urethritis in males. J\u00a0Infect Chemother 10:208\u2013211. https:\/\/doi.org\/10.1007\/s10156-004-0322-6","journal-title":"J Infect Chemother"},{"key":"3218_CR89","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1099\/jmm.0.071852-0","volume":"63","author":"A Samarawickrama","year":"2014","unstructured":"Samarawickrama\u00a0A, Cheserem\u00a0E, Graver\u00a0M et al (2014) Pilot study of use of the BioStar Optical ImmunoAssay GC point-of-care test for diagnosing gonorrhoea in men attending a\u00a0genitourinary medicine clinic. J\u00a0Med Microbiol 63:1111\u20131112. https:\/\/doi.org\/10.1099\/jmm.0.071852-0","journal-title":"J Med Microbiol"},{"key":"3218_CR90","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/JCM.03461-12","volume":"51","author":"CA Gaydos","year":"2013","unstructured":"Gaydos\u00a0CA, van der Pol\u00a0B, Jett-Goheen\u00a0M et al (2013) Performance of the Cepheid CT\/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J\u00a0Clin Microbiol 51:1666\u20131672. https:\/\/doi.org\/10.1128\/JCM.03461-12","journal-title":"J Clin Microbiol"},{"key":"3218_CR91","doi-asserted-by":"publisher","first-page":"e026888","DOI":"10.1136\/bmjopen-2018-026888","volume":"9","author":"N Garrett","year":"2019","unstructured":"Garrett\u00a0N, Mitchev\u00a0N, Osman\u00a0F et al (2019) Diagnostic accuracy of the Xpert CT\/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a\u00a0cross-sectional study. BMJ Open 9:e26888. https:\/\/doi.org\/10.1136\/bmjopen-2018-026888","journal-title":"BMJ Open"},{"issue":"Suppl 5","key":"3218_CR92","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1136\/sti.2006.024265","volume":"82","author":"RW Peeling","year":"2006","unstructured":"Peeling\u00a0RW, Holmes\u00a0KK, Mabey\u00a0D, Ronald\u00a0A (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 82(Suppl 5):v1\u2013v6. https:\/\/doi.org\/10.1136\/sti.2006.024265","journal-title":"Sex Transm Infect"},{"key":"3218_CR93","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1128\/JCM.01930-12","volume":"50","author":"SD Goldenberg","year":"2012","unstructured":"Goldenberg\u00a0SD, Finn\u00a0J, Sedudzi\u00a0E et\u00a0al (2012) Performance of the GeneXpert CT\/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual aptima samples. J\u00a0Clin Microbiol 50:3867\u20133869. https:\/\/doi.org\/10.1128\/JCM.01930-12","journal-title":"J Clin Microbiol"},{"key":"3218_CR94","first-page":"1021","volume":"3","author":"R Geiger","year":"2016","unstructured":"Geiger\u00a0R, Smith\u00a0DM, Little\u00a0SJ, Mehta\u00a0SR (2016) Validation of the GeneXpert(R) CT\/NG Assay for use with Male Pharyngeal and Rectal Swabs. Austin J HIV AIDS Res 3:1021","journal-title":"Austin J HIV AIDS Res"},{"key":"3218_CR95","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/OLQ.0000000000000627","volume":"44","author":"CC Bristow","year":"2017","unstructured":"Bristow\u00a0CC, McGrath\u00a0MR, Cohen\u00a0AC, Anderson\u00a0LJ, Gordon\u00a0KK, Klausner\u00a0JD (2017) Comparative evaluation of 2 nucleic acid amplification tests for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae at extragenital sites. Sex Transm Dis 44:398\u2013400. https:\/\/doi.org\/10.1097\/OLQ.0000000000000627","journal-title":"Sex Transm Dis"},{"key":"3218_CR96","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.diagmicrobio.2017.10.013","volume":"90","author":"L Dize","year":"2018","unstructured":"Dize\u00a0L, Silver\u00a0B, Gaydos\u00a0C (2018) Comparison of the Cepheid GeneXpert CT\/NG assay to the Hologic Aptima Combo2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in self-collected rectal swabs. Diagn Microbiol Infect Dis 90:83\u201384. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.10.013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3218_CR97","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/OLQ.0000000000001115","volume":"47","author":"A Footman","year":"2020","unstructured":"Footman\u00a0A, Dionne-Odom\u00a0J, Aaron\u00a0KJ, Raper\u00a0JL, Van Der Pol\u00a0B (2020) Performance of 4 molecular assays for detection of Chlamydia and gonorrhea in a\u00a0sample of human immunodeficiency virus-positive men who have sex with men. Sex Transm Dis 47:158\u2013161. https:\/\/doi.org\/10.1097\/OLQ.0000000000001115","journal-title":"Sex Transm Dis"},{"key":"3218_CR98","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/apm.12902","volume":"126","author":"S Jacobsson","year":"2018","unstructured":"Jacobsson\u00a0S, Boiko\u00a0I, Golparian\u00a0D et\u00a0al (2018) WHO laboratory validation of Xpert\u00ae CT\/NG and Xpert\u00ae TV on the GeneXpert system verifies high performances. APMIS 126:907\u2013912. https:\/\/doi.org\/10.1111\/apm.12902","journal-title":"APMIS"},{"key":"3218_CR99","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/OLQ.0000000000000865","volume":"45","author":"LE Widdice","year":"2018","unstructured":"Widdice\u00a0LE, Hsieh\u00a0YH, Silver\u00a0B, Barnes\u00a0M, Barnes\u00a0P, Gaydos\u00a0CA (2018) Performance of the Atlas genetics rapid test for Chlamydia trachomatis and women\u2019s attitudes toward point-of-care testing. Sex Transm Dis 45:723\u2013727. https:\/\/doi.org\/10.1097\/OLQ.0000000000000865","journal-title":"Sex Transm Dis"},{"key":"3218_CR100","unstructured":"Binx health (2020) https:\/\/mybinxhealth.com\/news\/binx-health-receives-fda-510k-clearance-for-rapid-point-of-care-platform-for-womens-health\/. Zugegriffen: 15. Apr. 2020"},{"key":"3218_CR101","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/sextrans-2014-051997","volume":"91","author":"G Brook","year":"2015","unstructured":"Brook\u00a0G (2015) The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays. Sex Transm Infect 91:539\u2013544. https:\/\/doi.org\/10.1136\/sextrans-2014-051997","journal-title":"Sex Transm Infect"},{"key":"3218_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"M Unemo","year":"2019","unstructured":"Unemo\u00a0M, Seifert\u00a0HS, Hook\u00a0EW 3rd et\u00a0al (2019) Gonorrhoea. Nat Rev Dis Primers 5:79. https:\/\/doi.org\/10.1038\/s41572-019-0128-6","journal-title":"Nat Rev Dis Primers"},{"key":"3218_CR103","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","volume":"17","author":"V Don\u00e0","year":"2017","unstructured":"Don\u00e0\u00a0V, Low\u00a0N, Golparian\u00a0D, Unemo\u00a0M (2017) Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. Expert Rev Mol Diagn 17:845\u2013859. https:\/\/doi.org\/10.1080\/14737159.2017.1360137","journal-title":"Expert Rev Mol Diagn"},{"key":"3218_CR104","unstructured":"Status of active applications to the prequalification of in vitro diagnostics. https:\/\/www.who.int\/diagnostics_laboratory\/pq_status\/en\/. Zugegriffen: 15. April 2020"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-020-03218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-020-03218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-020-03218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:19:41Z","timestamp":1631672381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-020-03218-4"}},"subtitle":["Gemeinsame Stellungnahme von DSTIG, RKI, PEI sowie den Referenzzentren f\u00fcr HIV, HBV und HCV und Konsiliarlaboren f\u00fcr Chlamydien, Gonokokken und Treponema pallidum"],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1007\/s00103-020-03218-4","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"15 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Meyer war als Berater f\u00fcr die Firma Roche t\u00e4tig und erhielt ein Beraterhonorar sowie als Referent f\u00fcr die Firma Cepheid und erhielt ein Vortragshonorar. J.\u00a0Eberle, R.\u00a0S.\u00a0Ro\u00df, C.G.\u00a0Sch\u00fcttler, M.\u00a0Baier, S.\u00a0Buder, P.K.\u00a0Kohl, D.\u00a0M\u00fcnstermann, H.-J.\u00a0Hagedorn, S.\u00a0Nick, K.\u00a0Jansen, V.\u00a0Bremer, M.\u00a0Mau und N.H.\u00a0Brockmeyer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}